{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:08:47Z","timestamp":1788876527196,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jneuroim.2026.579032","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:36:56Z","timestamp":1784129816000},"page":"579032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronic pain despite lower lesion burden in double-seronegative longitudinally extensive transverse myelitis"],"prefix":"10.1016","volume":"420","author":[{"given":"Yumin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hye","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynkyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyong","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahye","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jneuroim.2026.579032_bb0005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti\u2013IL-6 receptor antibody tocilizumab in neuromyelitis optica","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579032_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579032_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200188","article-title":"Serum biomarker profiles discriminate AQP4 seropositive and double seronegative neuromyelitis optica spectrum disorder","volume":"11","author":"Carta","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579032_bb0030","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579032_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresrev.2008.12.010","article-title":"Mechanisms of chronic central neuropathic pain after spinal cord injury","volume":"60","author":"Hulsebosch","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures","volume":"27","author":"Hurst","year":"2004","journal-title":"J. Manipulative Physiol. Ther."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579032_bb0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1352458514551454","article-title":"Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis","volume":"21","author":"Hyun","year":"2015","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579032_bb0060","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579032_bb0065","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jneuroim.2026.579032_bb0070","article-title":"Glial fibrillary acidic protein in blood as a disease biomarker of neuromyelitis optica spectrum disorders","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579032_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/13524585211024978","article-title":"Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder","volume":"28","author":"Kim","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.579032_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103500","article-title":"Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: cross-sectional and longitudinal analysis","volume":"58","author":"Kim","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0085","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1038\/s41598-023-30755-0","article-title":"Disease characteristics of idiopathic transverse myelitis with serum neuronal and astroglial damage biomarkers","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579032_bb0090","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579032_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2016.06.041","article-title":"Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status","volume":"368","author":"Kong","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579032_bb0100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaneurol.2024.2811","article-title":"Time to treat first acute attack of myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"81","author":"Kwon","year":"2024","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12883-022-02841-9","article-title":"The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200514","article-title":"Comparative effectiveness of disease-modifying treatments in double seronegative neuromyelitis optica spectrum disorder","volume":"13","author":"Mahler","year":"2026","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579032_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01773-w","article-title":"Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4\/MOG antibodies","volume":"17","author":"Maillart","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/21925682221109560","article-title":"Association between preoperative neuropathic pain and patient reported outcome measures after cervical spinal cord decompression surgery","volume":"14","author":"Nagata","year":"2024","journal-title":"Global Spine J."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579032_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579032_bb0135","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","article-title":"Association of neuromyelitis optica with severe and intractable pain","volume":"69","author":"Qian","year":"2012","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579032_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579032_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/13524585231221664","article-title":"The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis","volume":"30","author":"Rocchi","year":"2024","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579032_bb0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/papr.12472","article-title":"Korean version of the painDETECT questionnaire: a study for cultural adaptation and validation","volume":"17","author":"Sung","year":"2017","journal-title":"Pain Pract."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the brief pain inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3988\/jcn.2025.0321","article-title":"Consistent detection of aquaporin-4 antibodies: a comparative analysis between fixed and live cell-based assays","volume":"22","author":"Wang","year":"2026","journal-title":"J. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579032_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:25:12Z","timestamp":1788873912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0165572826001815"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579032","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic pain despite lower lesion burden in double-seronegative longitudinally extensive transverse myelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579032"}}